$43.90
Value $2.8B
ACMR and AVGO stock compared: price, dividend, valuation and results, from SEC filings.
$43.90
Value $2.8B
$354.05
Value $1.68T
ACM Research (ACMR) has a market value of $2.8B and Broadcom (AVGO) $1.68T. Over the last year, with dividends, ACMR moved +39.5% and AVGO +4.1%. The P/E is 24.3 for ACMR and 43.9 for AVGO. Dividend yield: ACMR none, AVGO 0.73%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
ACMR$2.8B
AVGO$1.68T
AVGO is 596 times ACMR
Revenue, 12 months
ACMR$1.1B
AVGO$89.1B
AVGO is 78 times ACMR
Net income, 12 months
ACMR$116M
AVGO$38.3B
AVGO is 330 times ACMR
Operating margin
ACMR14.5%
AVGO48.1%
33.6 points apart
ROIC
ACMR7.4%
AVGO27.3%
19.9 points apart
P/E
ACMR24.3
AVGO43.9
AVGO is 1.8 times ACMR
Dividend yield
ACMR0.0%
AVGO0.7%
0.7 points apart
5-year return
ACMR+30.7%
AVGO+579.0%
548.3 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
ACMR+30.7%
AVGO+579.0%
| Period | ACMRWith dividends | AVGOWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | +39.5%Price +39.5% | +4.1%Price +3.3% |
| 3 years since November 17, 2023 | +148.3%+35.4% a yearPrice +148.3% | +274.0%+55.2% a yearPrice +262.1% |
| 5 years since November 17, 2021 | +30.7%+5.5% a yearPrice +30.7% | +579.0%+46.7% a yearPrice +521.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
ACMRACM ResearchAVGOBroadcom
| Price | $43.90 | $354.05 |
|---|---|---|
| Market value | $2.8B | $1.68T |
| Enterprise value (EV) | $2.1B | $1.71T |
| P/E | 24.3 | 43.9 |
| P/E, 5-year median | 16.8 | 30.4 |
| P/B | 1.5 | 16.8 |
| EV/EBIT | 13.0 | 40.0 |
| Free cash flow yield | – | 2.4% |
| Revenue, 12 months | $1.1B | $89.1B |
|---|---|---|
| Net income, 12 months | $116M | $38.3B |
| Free cash flow, 12 months | -$199M | $39.4B |
| Earnings per share, 12 months | $1.60 | $7.84 |
| Revenue growth, year on year | 15.2% | 23.9% |
| Revenue growth a year, past | +41.9%over 5 years | +21.7%over 5 years |
| EPS growth a year, past | +35.5%over 5 years | +49.8%over 5 years |
| Gross margin | 43.5% | 68.8% |
|---|---|---|
| Operating margin | 14.5% | 48.1% |
| Net margin | 10.2% | 42.9% |
| ROIC | 7.4% | 27.3% |
| ROE | 7.0% | 45.4% |
| Cash | $952M | $24.0B |
|---|---|---|
| Total debt | $287M | $59.4B |
| Net debt / EBITDA | -3.8 | 0.8 |
| Interest cover | 22.4× | 13.7× |
| Dividend yield | – | 0.7% |
|---|---|---|
| Dividend per share, 12 months | – | $2.60 |
| Dividend growth a year, past | – | +12.7%over 5 years |
| Buyback yield | 0.3% | 0.2% |
| Shareholder yield | 0.3% | 0.9% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Broadcom ($1.68T) is about 595.7 times ACM Research ($2.8B), at today's prices.
Since November 17, 2021, ACMR's price moved +30.7% and AVGO's +521.6%. With dividends: ACMR +30.7% (+5.5% a year), AVGO +579.0% (+46.7% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for ACM Research and 0.73% for Broadcom. Over the last twelve months they paid – and $2.60 per share.
At today's price, the P/E is 24.3 for ACMR and 43.9 for AVGO. The median of the last five years was 16.8 and 30.4, which shows where each stands against its own past.
Over the last twelve months, the net margin was 10.2% for ACM Research and 42.9% for Broadcom, and the operating margin 14.5% and 48.1%. Revenue was $1.1B and $89.1B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.